WallStreetZenWallStreetZen

NASDAQ: DYN
Dyne Therapeutics Inc Stock Ownership - Who owns Dyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Dyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason P. RhodesDirector2026-07-0762,543$23.17
$1.45MSell
Jason P. RhodesDirector2026-07-07124,379$23.17
$2.88MSell
Jason P. RhodesDirector2026-07-075,000$23.61
$118.05kSell
Jason P. RhodesDirector2026-07-0711,665$23.62
$275.53kSell
Jason P. RhodesDirector2026-07-0729,587$23.62
$698.84kSell
Jason P. RhodesDirector2026-07-0749,193$23.17
$1.14MSell
Jason P. RhodesDirector2026-07-0714,844$23.62
$350.62kSell
Jason P. RhodesDirector2026-07-06100,019$22.79
$2.28MSell
Jason P. RhodesDirector2026-07-06253,039$22.79
$5.77MSell
Jason P. RhodesDirector2026-07-06127,182$22.79
$2.90MSell

1 of 12

DYN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DYN insiders and whales buy or sell their stock.

DYN Shareholders

What type of owners hold Dyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc18.62%30,785,801$752.40MInstitution
Janus Henderson Group PLC8.26%13,647,376$333.54MInstitution
Blackrock Inc7.08%11,699,870$285.94MInstitution
Atlas Venture Life Science Advisors LLC5.52%9,130,465$223.15MInstitution
Fmr LLC5.39%8,908,980$217.74MInstitution
Orbis Allan Gray Ltd4.09%6,762,231$165.27MInstitution
State Street Corp4.02%6,653,746$162.62MInstitution
Atlas Venture Fund XI LP3.97%6,562,578$160.39MInsider
Vanguard Capital Management LLC3.87%6,405,069$156.54MInstitution
Forbion Capital Fund IV Cooperatief Ua3.71%6,131,079$149.84MInsider

1 of 3

DYN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DYN84.70%15.30%Net SellingNet Selling
ACAD71.81%28.19%Net SellingNet Selling
CAI41.84%58.16%Net SellingNet Buying
VKTX63.04%8.85%Net Selling
VCYT67.25%32.75%Net SellingNet Selling
View Top Biotech Stocks

Dyne Therapeutics Stock Ownership FAQ

Who owns Dyne Therapeutics?

Dyne Therapeutics (NASDAQ: DYN) is owned by 113.63% institutional shareholders, 20.52% Dyne Therapeutics insiders, and 0.00% retail investors. Atlas Venture Fund XI LP is the largest individual Dyne Therapeutics shareholder, owning 6.56M shares representing 3.97% of the company. Atlas Venture Fund XI LP's Dyne Therapeutics shares are currently valued at $168.20M.

If you're new to stock investing, here's how to buy Dyne Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.